Cozad Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $28.5M | Buy |
23,746
+1,715
| +8% | +$1.75M | 1.84% | 10 |
|
|
2026
Q1 | $20.3M | Buy |
22,031
+452
| +2% | +$458K | 1.59% | 10 |
|
|
2025
Q4 | $23.2M | Sell |
21,579
-878
| -4% | -$840K | 1.8% | 8 |
|
|
2025
Q3 | $17.1M | Buy |
22,457
+762
| +4% | +$567K | 1.36% | 17 |
|
|
2025
Q2 | $16.9M | Buy |
21,695
+1,629
| +8% | +$1.27M | 1.48% | 11 |
|
|
2025
Q1 | $16.6M | Buy |
20,066
+963
| +5% | +$801K | 1.66% | 5 |
|
|
2024
Q4 | $14.7M | Buy |
19,103
+1,037
| +6% | +$859K | 1.38% | 13 |
|
|
2024
Q3 | $16M | Buy |
18,066
+2,193
| +14% | +$1.97M | 1.53% | 10 |
|
|
2024
Q2 | $14.4M | Buy |
15,873
+5,960
| +60% | +$4.77M | 1.43% | 14 |
|
|
2024
Q1 | $7.71M | Buy |
9,913
+6,804
| +219% | +$4.84M | 0.8% | 35 |
|
|
2023
Q4 | $1.81M | Sell |
3,109
-191
| -6% | -$111K | 0.21% | 125 |
|
|
2023
Q3 | $1.77M | Hold |
3,300
| – | – | 0.23% | 116 |
|
|
2023
Q2 | $1.55M | Sell |
3,300
-120
| -4% | -$50.3K | 0.19% | 134 |
|
|
2023
Q1 | $1.17M | Hold |
3,420
| – | – | 0.16% | 157 |
|
|
2022
Q4 | $1.25M | Buy |
3,420
+611
| +22% | +$217K | 0.18% | 151 |
|
|
2022
Q3 | $908K | Sell |
2,809
-20
| -0.7% | -$6.34K | 0.15% | 167 |
|
|
2022
Q2 | $917K | Buy |
2,829
+20
| +0.7% | +$6K | 0.14% | 163 |
|
|
2022
Q1 | $804K | Buy |
2,809
+1,045
| +59% | +$269K | 0.11% | 183 |
|
|
2021
Q4 | $487K | Sell |
1,764
-279
| -14% | -$70.7K | 0.07% | 227 |
|
|
2021
Q3 | $472K | Hold |
2,043
| – | – | 0.07% | 217 |
|
|
2021
Q2 | $469K | Hold |
2,043
| – | – | 0.07% | 219 |
|
|
2021
Q1 | $382K | Buy |
2,043
+240
| +13% | +$46.9K | 0.06% | 245 |
|
|
2020
Q4 | $304K | Hold |
1,803
| – | – | 0.05% | 255 |
|
|
2020
Q3 | $267K | Buy |
1,803
+120
| +7% | +$18.6K | 0.05% | 270 |
|
|
2020
Q2 | $276K | Hold |
1,683
| – | – | 0.06% | 261 |
|
|
2020
Q1 | $233K | Sell |
1,683
-320
| -16% | -$44K | 0.08% | 185 |
|
|
2019
Q4 | $263K | Sell |
2,003
-115
| -5% | -$13.3K | 0.07% | 210 |
|
|
2019
Q3 | $237K | Sell |
2,118
-285
| -12% | -$31.7K | 0.07% | 215 |
|
|
2019
Q2 | $266K | Sell |
2,403
-90
| -4% | -$10.6K | 0.08% | 204 |
|
|
2019
Q1 | $323K | Hold |
2,493
| – | – | 0.1% | 181 |
|
|
2018
Q4 | $288K | Buy |
2,493
+159
| +7% | +$17.8K | 0.1% | 184 |
|
|
2018
Q3 | $250K | Buy |
+2,334
| New | +$233K | 0.07% | 207 |
|
Other funds holding LLY
Cozad Asset Management's LLY Position: Q2 2026 in Review
Cozad Asset Management increased its Eli Lilly (LLY) stake by 7.8% in Q2 2026, buying an estimated $1.75M and bringing the position to 23,746 shares worth $28.5M. The position accounts for 1.84% of the portfolio, ranked #10.
Cozad Asset Management first reported a position in LLY in Q3 2018 and has held it in 32 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Cozad Asset Management held 23,746 shares of Eli Lilly worth $28.5M as of Q2 2026.
- Cozad Asset Management bought 1,715 Eli Lilly shares in Q2 2026, an estimated $1.75M.
- Eli Lilly made up 1.84% of Cozad Asset Management's portfolio in Q2 2026, its #10 holding.
- Cozad Asset Management first reported a position in Eli Lilly in Q3 2018 and has held it in 32 quarters since.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Cozad Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.